跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 34,907 条关于
“new chemical entities”
全部
34,907
临床试验
8,672
药物
351
机构
482
资讯
25,402
去年
Suven Life Sciences' Ropanicant Shows Positive Phase 2a Results for Major Depressive Disorder
8个月前
Amphastar Pharmaceuticals Advances Proprietary Pipeline with Novel Eye Drop and Cancer Therapies
去年
Reviva Presents Positive Speech Latency Data for Brilaroxazine in Schizophrenia from Phase 3 RECOVER Trial
7个月前
OEB 6 Emerges as New Manufacturing Standard for Ultra-Potent Oncology Drugs and ADCs
去年
Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer to Advance CNS Therapies
10个月前
Indero Develops 3-Day Microdosing Method to Accelerate Topical Drug Development Using Gene Expression Analysis
去年
India's ₹5,000 Crore PRIP Scheme Signals Major Shift from Generic Manufacturing to Innovation-Led Pharma Growth
去年
Reviva Pharma's Brilaroxazine Shows Positive Speech Latency Data in Phase 3 Schizophrenia Trial
10个月前
Zydus Lifesciences Secures First Drug Approval in China for Venlafaxine ER Capsules
去年
Reviva Presents Positive Brilaroxazine Data on Speech Latency in Schizophrenia from Phase 3 RECOVER Trial
第 1 页,共 2541 页
上一页
下一页